From: The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity
 | MMP-9 | TIMP-1 | MMP-9/TIMP-1 | |||
---|---|---|---|---|---|---|
r | p | r | p | r | p | |
FEV1/FVC | − 0.308 | 0.005 | − 0.085 | 0.456 | − 0.330 | 0.003 |
FVC (%) pred | − 0.294 | 0.008 | − 0.043 | 0.704 | − 0.282 | 0.011 |
FEV1 (%) pred | − 0.367 | p ≤ 0.001 | − 0.054 | 0.636 | − 0.392 | p ≤ 0.001 |
DLCO (%) pred | − 0.154 | 0.172 | − 0.117 | 0.302 | − 0.153 | 0.175 |
TLC (%) pred | 0.012 | 0.918 | − 0.119 | 0.293 | 0.105 | 0.355 |
RV (%) pred | 0.220 | 0.050 | − 0.031 | 0.786 | 0.277 | 0.013 |
VC (%) pred | − 0.323 | 0.003 | − 0.152 | 0.178 | − 0.263 | 0.018 |
RV% TLC pred | 0.308 | 0.005 | 0.015 | 0.895 | 0.335 | 0.002 |
IC (%) pred | − 0.359 | p ≤ 0.001 | − 0.148 | 0.189 | − 0.291 | 0.009 |
BMI (kg/m2) | 0.157 | 0.164 | 0.289 | 0.009 | 0.043 | 0.703 |
CRP (mg/l) | 0.301 | 0.007 | 0.370 | 0.001 | 0.164 | 0.148 |
WBC (10 ^ 9/l) | 0.462 | p ≤ 0.001 | 0.293 | 0.009 | 0.339 | 0.002 |
Ne (10 ^ 9/l) | 0.478 | p ≤ 0.001 | 0.346 | 0.002 | 0.322 | 0.004 |
Ne (%) | 0.315 | 0.005 | 0.225 | 0.046 | 0.194 | 0.086 |
Eo (10 ^ 9/l) | 0.016 | 0.890 | 0.007 | 0.949 | 0.045 | 0.698 |
Eo (%) | − 0.140 | 0.222 | − 0.175 | 0.125 | −0.038 | 0.743 |
Hgb (g/l) | 0.352 | 0.002 | 0.263 | 0.020 | 0.243 | 0.032 |
CAT | 0.273 | 0.014 | 0.053 | 0.641 | 0.312 | 0.005 |
mMRC | 0.288 | 0.010 | 0.103 | 0.365 | 0.281 | 0.011 |